Animation - Understanding NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET
This animation provides an overview of treatments for less common mutations in non-small cell lung cancer (NSCLC): ALK, BRAF, ROS1, HER2, and MET. The good news is that specific treatments can target these mutations. Watch to learn about different targeted therapy treatment options, common side effects, the importance of clinical trials, and more.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Other Modules:
Animation - Understanding NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET
Slide Show - Understanding NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET
1.
What is a gene mutation and how does it relate to lung cancer?
2.
How do doctors test for genetic mutations in lung cancer and why is it important?
3.
What is an ALK rearrangement in lung cancer?
4.
How do doctors treat ALK-rearranged lung cancer?
5.
What is a BRAF mutation in lung cancer?
6.
How do doctors treat lung cancer with BRAF mutations?
7.
What is a ROS1 mutation in lung cancer?
8.
How do doctors treat lung cancer with ROS1 mutations?
9.
What is a HER2 mutation in lung cancer?
10.
How do doctors treat lung cancer with HER2 mutations?
11.
What is a MET mutation in non-small cell lung cancer (NSCLC)?
12.
How do doctors treat lung cancer with MET mutations?
